Aranda-Guillén M

No link between type I interferon autoantibody positivity and adverse reactions to COVID-19 vaccines.

Yalcinkaya A, Cavalli M, Cederholm A, ..., Wadelius M, Landegren N

NPJ Vaccines 9 (1) 42 [2024-02-22; online 2024-02-22]

Autoimmunity and Serology Profiling [Service]

Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency.

Le Voyer T, Parent AV, Liu X, ..., Casanova JL, Puel A

Nature - (-) - [2023-11-08; online 2023-11-08]

Autoimmunity and Serology Profiling [Service]

Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis

Lemarquis A, Campbell T, Aranda-Guillén M, ..., Berg S, Ekwall O

Journal of Allergy and Clinical Immunology 148 (1) 96-98 [2021-07-00; online 2021-07-00]

Autoimmunity and Serology Profiling [Service]

GWAS for autoimmune Addison's disease identifies multiple risk loci and highlights AIRE in disease susceptibility.

Eriksson D, Røyrvik EC, Aranda-Guillén M, ..., Kämpe O, Husebye ES

Nat Commun 12 (1) 959 [2021-02-11; online 2021-02-11]

Bioinformatics Support for Computational Resources [Service]